Details for Patent: 11,590,205

✉ Email this page to a colleague

Patent 11,590,205 protects GVOKE HYPOPEN, GVOKE KIT, and GVOKE PFS, and is included in one NDA.

This patent has twenty-four patent family members in fifteen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Xeris	GVOKE HYPOPEN	glucagon	SOLUTION;SUBCUTANEOUS	212097-003	Sep 10, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF SEVERE HYPOGLYCEMIA	⤷ Sign Up
Xeris	GVOKE HYPOPEN	glucagon	SOLUTION;SUBCUTANEOUS	212097-004	Sep 10, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF SEVERE HYPOGLYCEMIA	⤷ Sign Up
Xeris	GVOKE KIT	glucagon	SOLUTION;SUBCUTANEOUS	212097-005	Aug 20, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF SEVERE HYPOGLYCEMIA	⤷ Sign Up
Xeris	GVOKE PFS	glucagon	SOLUTION;SUBCUTANEOUS	212097-001	Sep 10, 2019		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF SEVERE HYPOGLYCEMIA	⤷ Sign Up
Xeris	GVOKE PFS	glucagon	SOLUTION;SUBCUTANEOUS	212097-002	Sep 10, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF SEVERE HYPOGLYCEMIA	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016326749	⤷ Sign Up
Brazil	112018005800	⤷ Sign Up
Canada	2999404	⤷ Sign Up
Canada	3204984	⤷ Sign Up
China	108135980	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration